MHC heterozygosity limits T cell receptor variability in CD4 T cells
Science Immunology · 2024
DOI: 10.1126/sciimmunol.ado5295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2024. Verfasst von Alexander J Brown und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Genomic Medicine, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Major Histocompatibility Complex. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
αβ T cell receptor (TCR) V(D)J genes code for billions of TCR combinations. However, only some appear on peripheral T cells in any individual because, to mature, thymocytes must react with low affinity but not high affinity with thymus expressed major histocompatibility (MHC)/peptides. MHC proteins are very polymorphic. Different alleles bind different peptides. Therefore, any individual might express many different MHC alleles to ensure that some peptides from an invader are bound to MHC and activate T cells. However, most individuals express limited numbers of MHC alleles. To explore this, we compared the TCR repertoires of naïve CD4 T cells in mice expressing one or two MHC alleles. Unexpectedly, the TCRs in heterozygotes were less diverse that those in the sum of their MHC homozygous relatives. Our results suggest that thymus negative selection cancels out the advantages of increased thymic positive selection in the MHC heterozygotes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Genomic Medicine, National Jewish Health, 1400 Jackson St, Denver, CO 80206, USA.
- Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, 12800 East 19th Avenue, Aurora, CO 80045, USA.
- Department of Immunology, University of Oslo and Oslo University Hospital, Postboks 4950 Nydalen OUS HF Rikshospitalet, 0424 Oslo, Norway.
- Barbara Davis Center for Childhood Diabetes, University of Colorado Anschutz Medical Campus, 1775 Aurora Ct, Aurora, CO 80045, USA.
ORCID-Profile: Alexander J Brown, Laura Shaw, Andrei Slabodkin, Victor Greiff, Jennifer Matsuda, Laurent Gapin, John Kappler, Philippa Marrack
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Brown, A. J., White, J., Shaw, L., Gross, J., Slabodkin, A., Kushner, E., Greiff, V., Matsuda, J., Gapin, L., Scott-Browne, J., Kappler, J., & Marrack, P. (2024). MHC heterozygosity limits T cell receptor variability in CD4 T cells. Science Immunology. https://doi.org/10.1126/sciimmunol.ado5295
Vancouver
Brown AJ, White J, Shaw L, Gross J, Slabodkin A, Kushner E, et al. MHC heterozygosity limits T cell receptor variability in CD4 T cells. Science Immunology. 2024. doi:10.1126/sciimmunol.ado5295
BibTeX
@article{Brown2024,
author = {Brown, Alexander J and White, Janice and Shaw, Laura and Gross, Jimmy and Slabodkin, Andrei and Kushner, Ella and Greiff, Victor and Matsuda, Jennifer and Gapin, Laurent and Scott-Browne, James and Kappler, John and Marrack, Philippa},
title = {MHC heterozygosity limits T cell receptor variability in CD4 T cells},
journal = {Science Immunology},
year = {2024},
doi = {10.1126/sciimmunol.ado5295}
}
EUVIMED